サマリー

パラセタモールの世界市場 2023-2027
パラセタモール市場は、2022年から2027年の間に791.9百万米ドルで成長し、予測期間中のCAGRは8.78%で加速すると予測されます。当レポートでは、パラセタモール市場の全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。パラセタモールは、多くの一般用医薬品に原薬として使用されていること、症状緩和のための第一選択薬として広く使用されていること、慢性疾患や処方薬の使用率が上昇していることなどが市場を牽引しています。
Technavioのパラセタモール市場は以下のようにセグメント化されています：
用途別
- 外科用
- 非外科手術用
製剤別
- 粉末
- 顆粒
地域別構成比
- 北アメリカ
- ヨーロッパ
- アジア
- その他の地域(ROW)
本調査では、今後数年間のパラセタモール市場の成長を促進する主な理由の一つとして、パラセタモールベースの組み合わせの承認数が増加していることを挙げています。また、医療費の増加やパラセタモールの新しい用途の開発は、市場の大きな需要につながります。
本レポートでは、パラセタモール市場について、以下の分野を取り上げています：
- パラセタモール市場のサイジング
- パラセタモール市場の予測
- パラセタモール市場の産業分析
本レポートでは、パラセタモール市場の主要ベンダーであるAnhui Fubore Pharmaceutical And Chemical Co.Ltd.、Anqiu Luan Pharmaceutical Co.Ltd.、ATABAY KIMYA SANAYI TICARET AS、Biological E. Ltd.、Cipla Ltd.、GlaxoSmithKline Plc、Granules India Ltd., Mallinckrodt Plc, Sanofi SA, SEQENS GROUP、Sri Krishna Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Trugen Pharmaceuticals Pvt Ltd., Zhejiang Kangle Pharmaceutical Co.Ltd.、浙江康楽薬業有限公司、鄭州西濃化工有限公司の5社です。Ltd.の4社です。また、パラセタモール市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - https://www.technavio.com/report/paracetamol-market-industry-analysis
本書は、利益、価格、競争、プロモーションなどの主要なパラメータを分析し、複数のソースからのデータを調査、合成、要約することによって、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することにより、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。市場調査レポートでは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Formulation
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global paracetamol market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global paracetamol market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 Formulation Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Surgical - Market size and forecast 2022-2027
o Exhibit 34: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Surgical - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
o 6.4 Non-surgical - Market size and forecast 2022-2027
o Exhibit 38: Chart on Non-surgical - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Non-surgical - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Non-surgical - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Non-surgical - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Application
o Exhibit 42: Market opportunity by Application ($ million)
o Exhibit 43: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Formulation
o 7.1 Market segments
o Exhibit 44: Chart on Formulation - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Formulation - Market share 2022-2027 (%)
o 7.2 Comparison by Formulation
o Exhibit 46: Chart on Comparison by Formulation
o Exhibit 47: Data Table on Comparison by Formulation
o 7.3 Powder - Market size and forecast 2022-2027
o Exhibit 48: Chart on Powder - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Powder - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Powder - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Powder - Year-over-year growth 2022-2027 (%)
o 7.4 Granules - Market size and forecast 2022-2027
o Exhibit 52: Chart on Granules - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Granules - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Granules - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Granules - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Formulation
o Exhibit 56: Market opportunity by Formulation ($ million)
o Exhibit 57: Data Table on Market opportunity by Formulation ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 95: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Anhui Fubore Pharmaceutical And Chemical Co. Ltd.
o Exhibit 107: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Overview
o Exhibit 108: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Product / Service
o Exhibit 109: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Key offerings
o 12.4 Anqiu Luan Pharmaceutical Co. Ltd.
o Exhibit 110: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
o Exhibit 111: Anqiu Luan Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 112: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
o 12.5 ATABAY KIMYA SANAYI TICARET AS
o Exhibit 113: ATABAY KIMYA SANAYI TICARET AS - Overview
o Exhibit 114: ATABAY KIMYA SANAYI TICARET AS - Product / Service
o Exhibit 115: ATABAY KIMYA SANAYI TICARET AS - Key offerings
o 12.6 Biological E. Ltd.
o Exhibit 116: Biological E. Ltd. - Overview
o Exhibit 117: Biological E. Ltd. - Product / Service
o Exhibit 118: Biological E. Ltd. - Key offerings
o 12.7 Cipla Ltd.
o Exhibit 119: Cipla Ltd. - Overview
o Exhibit 120: Cipla Ltd. - Business segments
o Exhibit 121: Cipla Ltd. - Key news
o Exhibit 122: Cipla Ltd. - Key offerings
o Exhibit 123: Cipla Ltd. - Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 124: GlaxoSmithKline Plc - Overview
o Exhibit 125: GlaxoSmithKline Plc - Business segments
o Exhibit 126: GlaxoSmithKline Plc - Key news
o Exhibit 127: GlaxoSmithKline Plc - Key offerings
o Exhibit 128: GlaxoSmithKline Plc - Segment focus
o 12.9 Granules India Ltd.
o Exhibit 129: Granules India Ltd. - Overview
o Exhibit 130: Granules India Ltd. - Product / Service
o Exhibit 131: Granules India Ltd. - Key news
o Exhibit 132: Granules India Ltd. - Key offerings
o 12.10 Mallinckrodt Plc
o Exhibit 133: Mallinckrodt Plc - Overview
o Exhibit 134: Mallinckrodt Plc - Business segments
o Exhibit 135: Mallinckrodt Plc - Key news
o Exhibit 136: Mallinckrodt Plc - Key offerings
o Exhibit 137: Mallinckrodt Plc - Segment focus
o 12.11 Sanofi SA
o Exhibit 138: Sanofi SA - Overview
o Exhibit 139: Sanofi SA - Business segments
o Exhibit 140: Sanofi SA - Key news
o Exhibit 141: Sanofi SA - Key offerings
o Exhibit 142: Sanofi SA - Segment focus
o 12.12 SEQENS GROUP
o Exhibit 143: SEQENS GROUP - Overview
o Exhibit 144: SEQENS GROUP - Product / Service
o Exhibit 145: SEQENS GROUP - Key offerings
o 12.13 Sri Krishna Pharmaceuticals Ltd.
o Exhibit 146: Sri Krishna Pharmaceuticals Ltd. - Overview
o Exhibit 147: Sri Krishna Pharmaceuticals Ltd. - Product / Service
o Exhibit 148: Sri Krishna Pharmaceuticals Ltd. - Key offerings
o 12.14 Sun Pharmaceutical Industries Ltd.
o Exhibit 149: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 150: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 151: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 152: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 153: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 154: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 156: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.16 Zhejiang Kangle Pharmaceutical Co. Ltd.
o Exhibit 157: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
o Exhibit 158: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 159: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Zhengzhou Sino Chemical Co. Ltd.
o Exhibit 160: Zhengzhou Sino Chemical Co. Ltd. - Overview
o Exhibit 161: Zhengzhou Sino Chemical Co. Ltd. - Product / Service
o Exhibit 162: Zhengzhou Sino Chemical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global paracetamol market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Formulation Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Surgical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Surgical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Surgical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-surgical - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-surgical - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-surgical - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-surgical - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Formulation - Market share 2022-2027 (%)
Exhibits45: Data Table on Formulation - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Formulation
Exhibits47: Data Table on Comparison by Formulation
Exhibits48: Chart on Powder - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Powder - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Powder - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Powder - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Granules - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Granules - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Granules - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Granules - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Formulation ($ million)
Exhibits57: Data Table on Market opportunity by Formulation ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Overview
Exhibits108: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Product / Service
Exhibits109: Anhui Fubore Pharmaceutical And Chemical Co. Ltd. - Key offerings
Exhibits110: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
Exhibits111: Anqiu Luan Pharmaceutical Co. Ltd. - Product / Service
Exhibits112: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
Exhibits113: ATABAY KIMYA SANAYI TICARET AS - Overview
Exhibits114: ATABAY KIMYA SANAYI TICARET AS - Product / Service
Exhibits115: ATABAY KIMYA SANAYI TICARET AS - Key offerings
Exhibits116: Biological E. Ltd. - Overview
Exhibits117: Biological E. Ltd. - Product / Service
Exhibits118: Biological E. Ltd. - Key offerings
Exhibits119: Cipla Ltd. - Overview
Exhibits120: Cipla Ltd. - Business segments
Exhibits121: Cipla Ltd. - Key news
Exhibits122: Cipla Ltd. - Key offerings
Exhibits123: Cipla Ltd. - Segment focus
Exhibits124: GlaxoSmithKline Plc - Overview
Exhibits125: GlaxoSmithKline Plc - Business segments
Exhibits126: GlaxoSmithKline Plc - Key news
Exhibits127: GlaxoSmithKline Plc - Key offerings
Exhibits128: GlaxoSmithKline Plc - Segment focus
Exhibits129: Granules India Ltd. - Overview
Exhibits130: Granules India Ltd. - Product / Service
Exhibits131: Granules India Ltd. - Key news
Exhibits132: Granules India Ltd. - Key offerings
Exhibits133: Mallinckrodt Plc - Overview
Exhibits134: Mallinckrodt Plc - Business segments
Exhibits135: Mallinckrodt Plc - Key news
Exhibits136: Mallinckrodt Plc - Key offerings
Exhibits137: Mallinckrodt Plc - Segment focus
Exhibits138: Sanofi SA - Overview
Exhibits139: Sanofi SA - Business segments
Exhibits140: Sanofi SA - Key news
Exhibits141: Sanofi SA - Key offerings
Exhibits142: Sanofi SA - Segment focus
Exhibits143: SEQENS GROUP - Overview
Exhibits144: SEQENS GROUP - Product / Service
Exhibits145: SEQENS GROUP - Key offerings
Exhibits146: Sri Krishna Pharmaceuticals Ltd. - Overview
Exhibits147: Sri Krishna Pharmaceuticals Ltd. - Product / Service
Exhibits148: Sri Krishna Pharmaceuticals Ltd. - Key offerings
Exhibits149: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits150: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits151: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits152: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits153: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits154: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits155: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits156: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits157: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
Exhibits158: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
Exhibits160: Zhengzhou Sino Chemical Co. Ltd. - Overview
Exhibits161: Zhengzhou Sino Chemical Co. Ltd. - Product / Service
Exhibits162: Zhengzhou Sino Chemical Co. Ltd. - Key offerings
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations